MedPath

The effect of melatonin on patients with hemorrhagic stroke

Phase 2
Conditions
nontraumatic intracranial haemorrhage.
Intracranial haemorrhage (nontraumatic), unspecified
Registration Number
IRCT2016100530164N1
Lead Sponsor
Vice chancellor for research, Tehran university of medical sience
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

inclusion criteria: patients with hemorrhagic stroke who have been admitted within 72 hours after stroke

exclusion criteria:
liver failure (liver enzymes more than 3 fold); renal failure (GFR<60); patients with brain tumor

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
S100B. Timepoint: Before intervention and 5 days after initiation of intervention. Method of measurement: Laboratory Kit.
Secondary Outcome Measures
NameTimeMethod
GCS. Timepoint: Before the intervetion and 5 days after initiation of intervention. Method of measurement: GCS evaluating score.
© Copyright 2025. All Rights Reserved by MedPath